Faculty
-
August 30, 2016
Robert Klitzman on EpiPen's Price Hike
With EpiPen price-gouging in the news, Columbia's School of Professional Studies Bioethics Program Director, Dr. Robert Klitzman, has a new op-ed in CNN about the ethical questions raised by drug companies' overcharging patients. It's a tangled story of the principles of medicine, the profit priorities of private companies, and the taxpayers' money that creates these innovations.
Read the full article at CNN.
Faculty
Responding to climate-driven disasters requires long-term resilience, preparedness, and recovery planning.
Faculty
Columbia SPS lecturer Angela Finlay discusses her new book, Skill Stacking: Taking Ownership of Your Career in Changing Times, and why professionals and organizations need to rethink talent, experience, and career growth in a rapidly changing workplace.
Faculty
Designed for professionals seeking leadership roles, the Construction concentration equips students with the skills to navigate complexity, risk, and real-world project delivery.
All News
